Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism RIPK1 inhibitors(Receptor-interacting serine/threonine-protein kinase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H26N8O2 |
InChIKeyKDCYOEAWXNGQEB-UHFFFAOYSA-N |
CAS Registry2222286-49-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | BE | 08 Mar 2018 |